Insider · CIK 0001867450

Nabel Gary J.

Reports to the SEC for 3 companies · NEEDHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001867450

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-23	CADLCandel Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+32K sh	—	—	32,000
2026-06-09	SIGASIGA TECHNOLOGIES INCM Exercise/Conversion	Director	MExercise/Conversion	+24.1K sh	—	—	80,989
2026-06-09	SIGASIGA TECHNOLOGIES INCD Disposition to Issuer	Director	DDisposition to Issuer	−7,235 sh	$4.39	−$31.8K	73,754
2026-06-09	SIGASIGA TECHNOLOGIES INC · Restricted Stock UnitesM Exercise/Conversion	Director	MExercise/Conversion	−24.1K sh	—	—	0
2026-06-09	SIGASIGA TECHNOLOGIES INC · Restricted Stock UnitsA Award	Director	AAward	+34.2K sh	—	—	34,169
2025-06-25	CADLCandel Therapeutics, Inc.A Award	Director	AAward	+5,353 sh	$4.67	+$25K	5,353
2025-06-17	CADLCandel Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14.2K sh	—	—	14,240
2025-06-10	SIGASIGA TECHNOLOGIES INCM Exercise/Conversion	Director	MExercise/Conversion	+19.1K sh	—	—	62,598
2025-06-10	SIGASIGA TECHNOLOGIES INCD Disposition to Issuer	Director	DDisposition to Issuer	−5,725 sh	$6.22	−$35.6K	56,873
2025-06-10	SIGASIGA TECHNOLOGIES INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−19.1K sh	—	—	0
2025-06-10	SIGASIGA TECHNOLOGIES INC · Restricted Stock UnitsA Award	Director	AAward	+24.1K sh	—	—	24,116
2025-05-27	OPKOPKO HEALTH, INC. · Stock Option (Right to Buy)A Award	Director, Chief Innovation Officer	AAward	+438K sh	—	—	437,500
2024-07-24	OPKOPKO HEALTH, INC.A Award	Director, Chief Innovation Officer	AAward	+438K sh	—	—	700,579
2024-06-26	CADLCandel Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14.2K sh	—	—	14,240
2024-06-11	SIGASIGA TECHNOLOGIES INCM Exercise/Conversion	Director	MExercise/Conversion	+24.7K sh	—	—	50,928
2024-06-11	SIGASIGA TECHNOLOGIES INCD Disposition to Issuer	Director	DDisposition to Issuer	−7,414 sh	$7.86	−$58.3K	43,514
2024-06-11	SIGASIGA TECHNOLOGIES INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−24.7K sh	—	—	0
2024-06-11	SIGASIGA TECHNOLOGIES INC · Restricted Stock UnitsA Award	Director	AAward	+19.1K sh	—	—	19,084
2024-01-08	OPKOPKO HEALTH, INC.P Purchase	Director, Chief Innovation Officer	PPurchase	+109K sh	$0.93	+$101K	351,442
2024-01-08	OPKOPKO HEALTH, INC.P Purchase	Director, Chief Innovation Officer	PPurchase	+500 sh	$0.92	+$458.9	500
2024-01-08	OPKOPKO HEALTH, INC.P Purchase	Director, Chief Innovation Officer	PPurchase	+107K sh	$0.93	+$99.4K	107,489
2023-06-28	CADLCandel Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14.2K sh	—	—	14,240
2023-06-13	SIGASIGA TECHNOLOGIES INCM Exercise/Conversion	Director	MExercise/Conversion	+14.6K sh	—	—	30,602
2023-06-13	SIGASIGA TECHNOLOGIES INCD Disposition to Issuer	Director	DDisposition to Issuer	−4,386 sh	$6.07	−$26.6K	26,216
2023-06-13	SIGASIGA TECHNOLOGIES INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−14.6K sh	—	—	0
2023-06-13	SIGASIGA TECHNOLOGIES INC · Restricted Stock UnitsA Award	Director	AAward	+24.7K sh	—	—	24,712
2023-05-18	OPKOPKO HEALTH, INC. · Stock Option (Right to Buy)A Award	Director, Chief Innovation Officer	AAward	+700K sh	—	—	700,000
2023-05-05	OPKOPKO HEALTH, INC.P Purchase	Director, Chief Innovation Officer	PPurchase	+19.3K sh	$1.78	+$34.3K	94,756
2023-05-05	OPKOPKO HEALTH, INC.P Purchase	Director, Chief Innovation Officer	PPurchase	+3,185 sh	$1.79	+$5,710.705	97,941
2023-05-05	OPKOPKO HEALTH, INC.P Purchase	Director, Chief Innovation Officer	PPurchase	+27.8K sh	$1.80	+$50K	125,718
2023-05-05	OPKOPKO HEALTH, INC.P Purchase	Director, Chief Innovation Officer	PPurchase	+27.6K sh	$1.81	+$50K	153,342
2023-05-05	OPKOPKO HEALTH, INC.P Purchase	Director, Chief Innovation Officer	PPurchase	+79.3K sh	$1.82	+$144K	232,676
2023-05-05	OPKOPKO HEALTH, INC.P Purchase	Director, Chief Innovation Officer	PPurchase	+19.5K sh	$1.83	+$35.6K	252,151
2023-05-05	OPKOPKO HEALTH, INC.P Purchase	Director, Chief Innovation Officer	PPurchase	+10.9K sh	$1.83	+$20K	263,079
2023-05-05	OPKOPKO HEALTH, INC.P Purchase	Director, Chief Innovation Officer	PPurchase	+28.5K sh	$1.82	+$51.9K	19,886,052
2023-05-05	OPKOPKO HEALTH, INC.P Purchase	Director, Chief Innovation Officer	PPurchase	+26.4K sh	$1.85	+$48.9K	19,912,459
2023-05-05	OPKOPKO HEALTH, INC.P Purchase	Director, Chief Innovation Officer	PPurchase	+54.9K sh	$1.82	+$100K	19,912,459
2023-05-05	OPKOPKO HEALTH, INC.P Purchase	Director, Chief Innovation Officer	PPurchase	+34.3K sh	$1.84	+$63.1K	114,338
2023-05-05	OPKOPKO HEALTH, INC.P Purchase	Director, Chief Innovation Officer	PPurchase	+54.3K sh	$1.84	+$100K	168,684
2023-05-05	OPKOPKO HEALTH, INC.P Purchase	Director, Chief Innovation Officer	PPurchase	+20K sh	$1.85	+$37K	188,693
2023-05-05	OPKOPKO HEALTH, INC.P Purchase	Director, Chief Innovation Officer	PPurchase	+54.1K sh	$1.85	+$100K	242,747
2022-08-08	CADLCandel Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+28.5K sh	—	—	28,480
2022-06-22	OPKOPKO HEALTH, INC.P Purchase	Director, Chief Innovation Officer	PPurchase	+1,491 sh	$2.50	+$3,720.045	19,779,005
2022-06-22	OPKOPKO HEALTH, INC.P Purchase	Director, Chief Innovation Officer	PPurchase	+65.3K sh	$2.50	+$163K	19,844,285
2022-06-22	OPKOPKO HEALTH, INC.P Purchase	Director, Chief Innovation Officer	PPurchase	+13.2K sh	$2.50	+$33.1K	19,857,514
2022-06-22	OPKOPKO HEALTH, INC.P Purchase	Director, Chief Innovation Officer	PPurchase	+31K sh	$2.50	+$77.4K	19,808,537
2022-06-22	OPKOPKO HEALTH, INC.P Purchase	Director, Chief Innovation Officer	PPurchase	+15.2K sh	$2.50	+$38K	19,823,737
2022-06-22	OPKOPKO HEALTH, INC.P Purchase	Director, Chief Innovation Officer	PPurchase	+33.8K sh	$2.50	+$84.4K	19,857,514
2022-06-22	OPKOPKO HEALTH, INC.P Purchase	Director, Chief Innovation Officer	PPurchase	+80K sh	$2.47	+$198K	80,000
2022-06-14	SIGASIGA TECHNOLOGIES INCM Exercise/Conversion	Director	MExercise/Conversion	+22.8K sh	—	—	22,831

Recent filings

Accepted (ET)
Jun 244
Nabel Gary J.0001867450-26-000002
SEC(opens sec.gov)
Jun 104
Nabel Gary J.0001193125-26-266390
SEC(opens sec.gov)
Jun 264
Nabel Gary J.0000950170-25-090192
SEC(opens sec.gov)
Jun 184
Nabel Gary J.0000950170-25-087699
SEC(opens sec.gov)
Jun 114
Nabel Gary J.0000950170-25-084856
SEC(opens sec.gov)
May 294
Nabel Gary J.0000950170-25-079104
SEC(opens sec.gov)
Jul 264
Nabel Gary J.0000950170-24-087030
SEC(opens sec.gov)
Jun 274
Nabel Gary J.0000950170-24-078173
SEC(opens sec.gov)
Jun 134
Nabel Gary J.0000950170-24-073033
SEC(opens sec.gov)
Jan 104
Nabel Gary J.0000950170-24-003699
SEC(opens sec.gov)

Companies

Address

C/O CANDEL THERAPEUTICS, INC. 117 KENDRICK ST., SUITE 450

NEEDHAM, MA, 02494